These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 13090960)

  • 1. [The treatment of spastic states with hyoscine-N-butylbromide].
    HARTMANN HG
    Z Arztl Fortbild (Jena); 1953 Aug; 47(15):541-3. PubMed ID: 13090960
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyoscine butylbromide in labour.
    GARRETT AS; DRAPER VS
    Practitioner; 1963 May; 190():653-6. PubMed ID: 13960471
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the pharmacologic effect and clinical use of hyoscine-N-butylbromide (buscopan)].
    HEINKEL K
    Dtsch Z Verdau Stoffwechselkr; 1951 Jul; 11(4):180-95. PubMed ID: 14872696
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical effect of the spasmolytic agent hyoscine N-butylbromide (buscopan) in so-called spastic bronchitis in infants].
    GADEKE R
    Kinderarztl Prax; 1955 Nov; 23(11):486-92. PubMed ID: 13279076
    [No Abstract]   [Full Text] [Related]  

  • 5. [The muscle relaxant action of scopolamine butylbromide (buscopan)].
    PHILIPPOT E; DALLEMAGNE MJ
    Arch Int Pharmacodyn Ther; 1953 Apr; 93(3-4):337-40. PubMed ID: 13066127
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative studies on the effect of bile acids and scopolamine-N-butylbromide on intestinal motoricity].
    BERGMANN M
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1954; 223(4):311-3. PubMed ID: 13223807
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological and clinical observations on the combination of scopolamine N-butylbromide and aminopyrine sodium sulfonate (buscopan compositum)].
    MARINO A; MURARO U
    Rass Int Clin Ter; 1959 Dec; 39():1247-93 contd. PubMed ID: 14421165
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later.
    Campbell ML
    J Pain Symptom Manage; 2019 Jan; 57(1):e14-e15. PubMed ID: 30248383
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of hyoscine N-butyl bromide during labor].
    GUIAVARC'H R
    Sem Hop Ther Paris; 1960 May; 36():442-7. PubMed ID: 13830116
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter to the Editor Re: "Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later".
    Clark K; Sheehan C; Currow DC
    J Pain Symptom Manage; 2019 Jan; 57(1):e16-e17. PubMed ID: 30367928
    [No Abstract]   [Full Text] [Related]  

  • 11. [Post-anesthetic vomiting; the results of treatment with scopolamine-N-butylbromide (buscopan) and promethazine (fargan)].
    REVERBERI S; BOZZA ML
    Minerva Anestesiol; 1955 Sep; 21(9):205-12. PubMed ID: 13279605
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to "Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later".
    Boland JW; Currow D; Johnson M
    J Pain Symptom Manage; 2019 Mar; 57(3):e12-e13. PubMed ID: 30496789
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to "Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later".
    van Esch HJ; Geijteman ECT; van der Rijt CCD
    J Pain Symptom Manage; 2019 Apr; 57(4):e1-e2. PubMed ID: 30660674
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyoscine butylbromide and progress of labor in primigravidae: methodological concerns.
    Abbas AM
    J Matern Fetal Neonatal Med; 2019 Mar; 32(5):876. PubMed ID: 28918690
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical contribution to the study of hyoscine N-butylbromide (B 2011)].
    FORET J; SIMILON A
    J Belge Urol; 1952 Dec; 21(2):55-8. PubMed ID: 13044763
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic use of buscopan in spastic gastrointestinal diseases].
    BASS E; DIETRICH H
    Dtsch Med Wochenschr; 1952 Jul; 77(29-30):906-9. PubMed ID: 12979689
    [No Abstract]   [Full Text] [Related]  

  • 17. Atropine as an antisialogogue, compared with l-hyoscyamine (bellafoline), scopolamine butylbromide (buscopan) and oxyphenonium (antrenyl).
    DIAMANT H; FEINMESSER M
    Br J Anaesth; 1959 May; 31(5):205-9. PubMed ID: 13662482
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of hyoscine butylbromide on the duration and progress of labor in primigravidae: a randomized controlled trial: methodological issues.
    Ranjbaran M
    J Matern Fetal Neonatal Med; 2019 Mar; 32(6):1049. PubMed ID: 29046122
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to: The effect of hyoscine butylbromide on the duration and progress of labor in primigravidae: a randomized controlled trial: methodological issues.
    Maged A
    J Matern Fetal Neonatal Med; 2019 Mar; 32(6):1020-1021. PubMed ID: 29057697
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sonographic study of the effect of hyoscin-N-butylbromide on cholecystokinin stimulated gallbladder motility].
    Wagner T; Botzler R; Ritter U
    Z Gastroenterol; 1984 Jun; 22(6):305-10. PubMed ID: 6464523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.